Research

Clinical intelligence you can cite.

Request access to the full Klarity research catalog, co-authored with leading medical institutions.

These briefs and dashboards equip clinicians, employers, and researchers with the data needed to evaluate integration-forward ketamine care.

Featured briefs

Evidence packets & summaries

Dive deeper with downloadable PDFs or request restricted clinical data.

Analysis of 240 Klarity patients comparing IV, IM, and at-home ketamine programs with integration outcomes.

Randomized Cohort Integration

Co-authored with Stanford Pain Medicine, this paper explores the synergistic impact of stellate ganglion block and ketamine-assisted therapy.

PTSD Dual Modality

Anonymized data set showcasing leadership retention and innovation metrics after Klarity corporate retreats.

Leadership Performance

Outcome snapshots

Average PROMIS score increase

+38%

Across depression and anxiety cohorts after six-session ketamine series.

Integration adherence

92%

Patients completing 30-day integration assignments tied to clinical outcomes.

Corporate resilience ROI

4.2x

Innovation and retention value reported six months after Klarity retreats.

Library access

Researchers and medical directors can request anonymized data sets or schedule a briefing on methodology, instrumentation, and limitations.

Interactive view of symptom reduction, biomarker shifts, and retention metrics.

Downloadable ritual prompts, accountability trackers, and partner handoff briefs.

Annotated citations and PubMed links for the research we reference with partners.

Executive summary of leadership, culture, and innovation metrics post-retreat.